MaximBio Reveals Agreement with US DoD for ClearDetect ™ COVID-19 Antigen Home Test
MaximBio Reveals Agreement with US DoD for ClearDetect ™ COVID-19 Antigen Home Test

MaximBio Reveals Agreement with US DoD for ClearDetect ™ COVID-19 Antigen Home Test

DoD’s acquisition of MaximBio ClearDetect COVID-19 antigen home test must be funded through the American Rescue Plan Act to provide critical medical resources to the nation. Jonathan Maa, MaximBio’s Chief Operating Officer, commented on the contract: “The award from DoD makes sense given our partnership with DoD and NIH RADx, which helped fund the development of ClearDetect COVID-19 antigen home test. We look forward to continuing our collaboration with DoD to support the nation’s need for COVID-19 testing. “The fact that the test has been developed and will be manufactured in The United States is a source of pride for MaximBio and Mr. Must. He went on to say: “We at MaximBio are pleased that an American company, with a test designed and assembled in America, will support President Biden’s plan to deliver one billion free home COVID-19 tests to the nation in response to Omicron variant. “

That ClearDetect COVID-19 antigen home test is simple to perform, does not require a reader and consists of only 3 components – a cotton swab, a test strip and a test tube filled with sample buffer. As the test is read visually and does not require special equipment, its simplified operation can be easily performed at home or in the field.

That MaximBio ClearDetect COVID-19 antigen home test performed well compared to RT-PCR and achieved 86.9% positive agreement (PPA) and 98.9% negative agreement (NPA), making it one of the more sensitive and specific antigen tests available. The test has also been shown to detect all variants of concern, including Omicron.

The test will be available in two set configurations – packaged with two (2) tests in a box for practical home use and in a 25-test package that can be used for health environments, schools, workplaces, military bases and other high-volume test scenarios. MaximBio has increased production since the beginning of the year and has doubled its efforts in light of the DoD award.

About Maxim Biomedical Inc.

With headquarters in Rockville, MD, Maxim Biomedical is a leading diagnostic healthcare company that delivers innovative solutions through the development and manufacture of reliable test solutions. Our mission is to create diagnostic products that are affordable, accessible, and enable usable testing to improve patient outcomes around the globe.

For more information, visit maximbio.com, or contact [email protected]

SOURCE Maxim Biomedical, Inc.

Leave a Reply

Your email address will not be published.